Hi all, great news about GNBT/NGIO! We have a lot to look
Hi all, great news about GNBT/NGIO! We have a lot to look forward to and I cannot wait to see Joe up on Fox business or other major outlets providing insights on the safety and effectiveness profile of the Ii-key peptides.
Someone asked a question about what constitutes “development?” It would be a great question for the conference call to have that pathway be highlighted. I’m thinking that by development costs, it is all costs involved: (for example)
1. Identifying peptide chains
2. Testing peptides
3. All regulatory costs in gaining pre-IND and IND approvals
4. Costs for trials in any applicable country and for targeted populations
5. Educational awareness and marketing support costs
6. MFG costs
7. Logistics costs
of GNBT BK looks like it will cover country-specific costs for registration and regulatory costs and own the regulatory asset within those countries as well as the regulatory burden.
9. Licensing costs
Some time ago, GNBT put out a flow chart that may have described most of this pathway with a timeline. If someone has that available, I think it was the end of July. It may be material to review it at this time.
My thought is that BK is just the beginning and the costs will be shared by all partners of NGIO worldwide and that this is a repeatable blueprint that NGIO can use worldwide into developed and less developed countries. Many of us think based upon the USA and North America, but the better market when a mandatory vaccine is concerned is abroad. I believe this information when combined with the peptide results will finally garner the attention that GNBT has needed, and they will be ready to deliver.
Overall this is great news, and the move into other populations aside from adults is a great one that will provide niche success but as we have seen before within the medical device community if it is safe for the more vulnerable populace and II-key can boost based upon who is taking it, it may gain more favor in the adult population as a better choice.
7
Generex Biotechnology Corp. (GNBTQ) Stock Research Links
Scroll down for more posts ▼
Top 10 Most Recent News Articles
University's Innovative Approach to Learning Alright, here's something you don't see every day. The University of Phoenix managed to snag some kudos from an academic journal for using AI and storytelling to teach environmental science. That's like hitting two bulls-eyes with one shot in the world of education. The recognition from Glacies for this Editor's Choice paper...
Continue Reading
A Star-Studded Fantasy Comes Alive Hong Kong isn't just about dim sum and skyline views—it's a magnet for celebrity showcases, and this time, Jackson Wang's pulling the strings. The guy's ventured beyond music and idol fame, diving head-first into creative visuals with his fantasy IP, "Under the Castle" (UTC). Pairing up with Ocean Park's Halloween Fest, he's cooked up...
Continue Reading
Diving Deep into the Krispy Kreme Allegations Look, this isn't your run-of-the-mill donut drama. When you hear rumblings of corporate missteps, especially ones that involve potential breaches of fiduciary duties, it's time to perk up those ears. Over at Krispy Kreme, Inc. (NASDAQ:DNUT), there's some heat in the kitchen, and it's not just from frying those glazed beauties....
Continue Reading
Ah, sunglasses—the quintessential accessory that screams both practicality and style. A million-dollar look without the million-dollar expense? That's where Quay comes in. They've been recognized by Expert Consumers, no less, as some of the best-in-class for affordable luxury eye candy out there—aimed at shoppers who want the designer vibe without the hemorrhaging...
Continue Reading
PACS Group: Legal Storm Brewing Welcome to the latest saga in the volatile theater of corporate governance. PACS Group, Inc., ticker symbol NYSE:PACS, is under the microscope, and not for debuting a groundbreaking product or hitting a stock milestone. Nope, instead we've got Halper Sadeh LLC out of New York investigating some possible hanky-panky from PACS directors and...
Continue Reading
Shining a Light on Essential Family Farmers Every year, thousands gather for Farm Aid to back the unsung heroes who put food on our plates. In 2026, the scene shifted to the amphitheater at Virginia Beach, where an epic lineup of music took stage not just to entertain but to underline a critical issue—family farmers are fighting for survival. These folks aren't merely...
Continue Reading
Modular Solutions Steal the Show in Bangkok When a company draws 59,468 attendees from over 150 countries, folks pay attention—and that was exactly the scene at Gastech 2026 in Bangkok. The name buzzing on many lips? Endurance Energy. These guys showcased a fresh take on energy logistics with their skid-mounted liquefaction tech, turning heads with their Southeast Asia...
Continue Reading
The Investor Storm Brewing Over Honeywell Aerospace There it is again, another industry heavyweight caught in a dizzying whirlwind of litigation. Honeywell Aerospace Inc. (NASDAQ:HONA), a name as established as an old boot in the business, now faces a class action lawsuit that's got investors frantically dusting off phone numbers for their attorneys. The Messy Allegations...
Continue Reading
Taking Flight with Legacy and Tradition Throwing a bash on Times Square isn't just about flash; it's about letting folks know you mean business. And China Southern Airlines has been doing just that for 70 years. Imagine starting from Guangzhou and ending up splashed across New York City's giant LED screens—talk about a journey! From Humble Roots to Global Network...
Continue Reading
Unseen Perils of Winter Heating in Massachusetts Massachusetts homeowners, listen up. If your heating system is older than the Model T, it's time to rethink your winter strategy. You don't want to be stuck in the cold when the thermometer hits single digits, do you? That's where Townsend comes in, making waves with their rebate assistance program. Navigating the Rebate...
Continue Reading
Top 5 Most Recently Viewed Articles
Overview of Financial Results Park Aerospace Corp. (NYSE: PKE) has recently announced significant financial results for the fiscal year third quarter, showcasing resilience and growth despite various challenges faced in recent times. As a key player in the aerospace materials sector, Park continues to demonstrate its ability to drive sales and maintain profitability....
Continue Reading
Standard BioTools Adjusts Price Target Amid Market Challenges Recently, Standard BioTools Inc. (NASDAQ: LAB) had its price target updated to $2.50 from $2.75 by TD Cowen, sparking discussions about the company's current performance and future prospects. Despite this adjustment, TD Cowen has retained a Buy rating on the stock, indicating confidence in the company’s...
Continue Reading
WTW Increases Quarterly Dividend for Shareholders WTW, a prominent global leader in advisory and broking solutions, has made a significant announcement that is sure to please its investors. The company's Board of Directors has approved a regular quarterly cash dividend of $0.92 per common share. This marks a notable increase of 5% compared to the previous quarter's...
Continue Reading
Exciting News from REPT BATTERO REPT BATTERO is making significant strides in the energy storage industry with the official launch of its products at a major exposition. The company has unveiled innovative offerings that aim to improve the efficiency and safety of energy storage systems around the world. As part of its expansion strategy, REPT BATTERO has also opened a...
Continue Reading
WD-40 Company Reschedules Earnings Conference Call WD-40 Company (NASDAQ: WDFC) has made an important update regarding its upcoming Q1 FY25 earnings conference call. Initially planned for January 9, 2025, the call is now set to take place the following day, January 10, 2025, at 2:00 PM PST. This schedule adjustment comes in light of the recent announcement regarding stock...
Continue Reading